Sunesis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Sunesis and buy or sell other stocks, ETFs, and their options commission-free!About SNSS
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees—
Employees—
HeadquartersCardiff, California
HeadquartersCardiff, California
Founded1998
Founded1998
Employees—
Employees—
SNSS Key Statistics
Market cap365.25M
Market cap365.25M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume61.84K
Average volume61.84K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.846
52 Week high$0.846
52 Week low$0.008
52 Week low$0.008
People also own
Based on the portfolios of people who own SNSS. This list is generated using Robinhood data, and it’s not a recommendation.